147 related articles for article (PubMed ID: 33966225)
21. Development of an Endoscopic Auto-Fluorescent Sensing Device to Aid in the Detection of Breast Cancer and Inform Photodynamic Therapy.
Gaitan B; Inglut C; Kanniyappan U; Xu HN; Conant EF; Frankle L; Li LZ; Chen Y; Huang HC
Metabolites; 2022 Nov; 12(11):. PubMed ID: 36422237
[TBL] [Abstract][Full Text] [Related]
22. Optical redox imaging indices discriminate human breast cancer from normal tissues.
Xu HN; Tchou J; Feng M; Zhao H; Li LZ
J Biomed Opt; 2016 Nov; 21(11):114003. PubMed ID: 27896360
[TBL] [Abstract][Full Text] [Related]
23. Tryptophan hydroxylase 1 and 5-HT
Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
[TBL] [Abstract][Full Text] [Related]
24. KR-33028, a potent inhibitor of the Na
Amith SR; Wilkinson JM; Fliegel L
Biochem Pharmacol; 2016 Oct; 118():31-39. PubMed ID: 27521504
[TBL] [Abstract][Full Text] [Related]
25. Label-free metabolic imaging for sensitive and robust monitoring of anti-CD47 immunotherapy response in triple-negative breast cancer.
Yang M; Mahanty A; Jin C; Wong ANN; Yoo JS
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36096527
[TBL] [Abstract][Full Text] [Related]
26. Moderate intermittent negative pressure increases invasiveness of MDA-MB-231 triple negative breast cancer cells.
Liu W; Fu X; Yang Z; Li S; Cao Y; Li Q; Luan J
Breast; 2018 Apr; 38():14-21. PubMed ID: 29182982
[TBL] [Abstract][Full Text] [Related]
27. Feasibility of Non-invasive Measurement of Tumour NAD(H) by In Vivo Phosphorus-31 Magnetic Resonance Spectroscopy.
Nath K; Arias-Mendoza F; Xu HN; Gupta PK; Li LZ
Adv Exp Med Biol; 2022; 1395():237-242. PubMed ID: 36527643
[TBL] [Abstract][Full Text] [Related]
28. Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer.
Camorani S; Hill BS; Collina F; Gargiulo S; Napolitano M; Cantile M; Di Bonito M; Botti G; Fedele M; Zannetti A; Cerchia L
Theranostics; 2018; 8(18):5178-5199. PubMed ID: 30429893
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
[TBL] [Abstract][Full Text] [Related]
30. Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry.
Sun H; Zhang D; Yao Z; Lin X; Liu J; Gu Q; Dong X; Liu F; Wang Y; Yao N; Cheng S; Li L; Sun S
Cancer Biol Ther; 2017 Apr; 18(4):205-213. PubMed ID: 28278077
[TBL] [Abstract][Full Text] [Related]
31. Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133
Brugnoli F; Grassilli S; Lanuti P; Marchisio M; Al-Qassab Y; Vezzali F; Capitani S; Bertagnolo V
BMC Cancer; 2017 Sep; 17(1):617. PubMed ID: 28870198
[TBL] [Abstract][Full Text] [Related]
32. Optical Redox Imaging of Lonidamine Treatment Response of Melanoma Cells and Xenografts.
Xu HN; Feng M; Nath K; Nelson D; Roman J; Zhao H; Lin Z; Glickson J; Li LZ
Mol Imaging Biol; 2019 Jun; 21(3):426-435. PubMed ID: 30151646
[TBL] [Abstract][Full Text] [Related]
33. Fangjihuangqi Decoction inhibits MDA-MB-231 cell invasion in vitro and decreases tumor growth and metastasis in triple-negative breast cancer xenografts tumor zebrafish model.
Guo Y; Fan Y; Pei X
Cancer Med; 2020 Apr; 9(7):2564-2578. PubMed ID: 32037729
[TBL] [Abstract][Full Text] [Related]
34. LyP-1 Conjugated Nanoparticles for Magnetic Resonance Imaging of Triple Negative Breast Cancer.
Abulrob A; Corluka S; Blasiak B; Gino Fallone B; Ponjevic D; Matyas J; Tomanek B
Mol Imaging Biol; 2018 Jun; 20(3):428-435. PubMed ID: 29101636
[TBL] [Abstract][Full Text] [Related]
35. Protein Tyrosine Kinase 7 Regulates EGFR/Akt Signaling Pathway and Correlates With Malignant Progression in Triple-Negative Breast Cancer.
Cui NP; Qiao S; Jiang S; Hu JL; Wang TT; Liu WW; Qin Y; Wang YN; Zheng LS; Zhang JC; Ma YP; Chen BP; Shi JH
Front Oncol; 2021; 11():699889. PubMed ID: 34367983
[TBL] [Abstract][Full Text] [Related]
36. Endocan as a prognostic biomarker of triple-negative breast cancer.
Sagara A; Igarashi K; Otsuka M; Kodama A; Yamashita M; Sugiura R; Karasawa T; Arakawa K; Narita M; Kuzumaki N; Narita M; Kato Y
Breast Cancer Res Treat; 2017 Jan; 161(2):269-278. PubMed ID: 27888420
[TBL] [Abstract][Full Text] [Related]
37. [Effect of miRNA-135b on proliferation, invasion and migration of triple-negative breast cancer by targeting APC].
Xin H; Jiang D; Lü Z; Sun S; Kong J; Li F
Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(30):2474-7. PubMed ID: 26711213
[TBL] [Abstract][Full Text] [Related]
38. Spectroscopic Study of Time-Varying Optical Redox Ratio in NADH/FAD Solution.
Lim SY; Jang JI; Yoon H; Kim HM
J Phys Chem B; 2022 Dec; 126(47):9840-9849. PubMed ID: 36399328
[TBL] [Abstract][Full Text] [Related]
39. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer redox heterogeneity detectable with chemical exchange saturation transfer (CEST) MRI.
Cai K; Xu HN; Singh A; Moon L; Haris M; Reddy R; Li LZ
Mol Imaging Biol; 2014 Oct; 16(5):670-9. PubMed ID: 24811957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
